Profound Medical
PROF
44 hedge funds and large institutions have $84.6M invested in Profound Medical in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 6 closing their positions.
1,225% more call options, than puts
Call options by funds: $3.78M | Put options by funds: $285K
15% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.81% less ownership
Funds ownership: 47.07% → 45.26% (-1.8%)
4% less funds holding
Funds holding: 46 → 44 (-2)
23% less capital invested
Capital invested by funds: $110M → $84.6M (-$25.1M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
+$4.59M |
| 2 |
GS
Gagnon Securities
New York
|
+$2.38M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$578K |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$385K |
| 5 |
GA
Gagnon Advisors
New York
|
+$374K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Blackcrane Capital
Bellevue,
Washington
|
-$7.19M |
| 2 |
ACM
Altium Capital Management
New York
|
-$1.69M |
| 3 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$1.13M |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$851K |
| 5 |
RA
Royce & Associates
New York
|
-$592K |
PROF Hedge Fund Activity: Q1 2022 in Review
44 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q1 2022, worth a combined $84.6M — down 23% from $110M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PROF and 4 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 15 added.
The largest buyer was Letko, Brosseau & Associates, adding an estimated $4.59M. The largest seller was Blackcrane Capital, cutting an estimated $7.19M.
- 44 institutional investors held Profound Medical (PROF) as of Q1 2022, down from 46 in Q4 2021.
- Funds reported $84.6M of Profound Medical stock for Q1 2022, down 23% quarter-over-quarter.
- 4 funds opened new Profound Medical positions in Q1 2022 and 6 closed out, a net change of -2 holders.
- The largest Profound Medical buyer in Q1 2022 was Letko, Brosseau & Associates, an estimated $4.59M added.
- The largest Profound Medical seller in Q1 2022 was Blackcrane Capital, an estimated $7.19M sold.
Based on aggregated 13F filings for Q1 2022.